Mitsuhiro Kida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mitsuhiro Kida has a total of 166 co-authors. Here are the top co-authors by number of shared publications:
- Kosuke Okuwaki
Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan
29 shared publications - Hiroshi Imaizumi
Department of Gastroenterology, Kitasato University Hospital
22 shared publications - Wasaburo Koizumi
Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan
18 shared publications - Hiroshi Imaizumi
Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan
14 shared publications Hiroshi Yamauchi
Department of Gastroenterology, Graduate School of Medicine, Kitasato University Hospital, Kanagawa 252-0375, Japan
14 shared publicationsMaya Watanabe
Department of Gastroenterology, Kitasato University, Sagamihara, Japan
14 shared publications
Latest Publications
- Open Access
- 16 July 2026
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
Incidence of Cholecystitis after Multihole Fully Covered Metal Stent Placement for Unresectable Malignant Distal Biliary Obstruction: A Prospective Exploratory Study
Cholecystitis and stent migration are adverse events of fully covered self-expandable metal stents (SEMS) for malignant distal biliary obstruction. The aim of this study was to evaluate the incidence of cholecystitis, clinical outcomes, and safety of a multihole fully covered SEMS (MHSEMS) in unresectable malignant distal biliary obstruction. This single-center, prospective, exploratory study included consecutive patients who underwent MHSEMS placement for unresectable malignant distal biliary obstruction between June 2023 and January 2024. The primary endpoint was the incidence of cholecystitis. Stent patency was analyzed using the Kaplan–Meier method, and categorical variables were expressed as percentages. Twenty patients were enrolled, and all were followed for up to 1 year or until death; technical and clinical success rates were both 100%. No cholecystitis occurred despite the presence of reported risk factors for cholecystitis: cholelithiasis or sludge (65%), contrast filling of the gallbladder (35%), and tumor involvement of the cystic duct (15%). Recurrent biliary obstruction occurred in six patients (30%): two stent migrations, three occlusions, and one biliary kinking. All recurrent biliary obstruction cases were managed endoscopically. Median time to recurrent biliary obstruction was not reached. One-year stent patency rate was 62%. Adverse events other than recurrent biliary obstruction were mild. No cholecystitis occurred after MHSEMS placement in this small prospective cohort, suggesting a favorable safety profile; however, larger comparative studies are needed to clarify its effect. UMIN000051182; registered June 1, 2023.
- 16 July 2026
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
Open AccessIncidence of Cholecystitis after Multihole Fully Covered Metal Stent Placement for Unresectable Malignant Distal Biliary Obstruction: A Prospective Exploratory Study
Cholecystitis and stent migration are adverse events of fully covered self-expandable metal stents (SEMS) for malignant distal biliary obstruction. The aim of this study was to evaluate the incidence of cholecystitis, clinical outcomes, and safety of a multihole fully covered SEMS (MHSEMS) in unresectable malignant distal biliary obstruction. This single-center, prospective, exploratory study included consecutive patients who underwent MHSEMS placement for unresectable malignant distal biliary obstruction between June 2023 and January 2024. The primary endpoint was the incidence of cholecystitis. Stent patency was analyzed using the Kaplan–Meier method, and categorical variables were expressed as percentages. Twenty patients were enrolled, and all were followed for up to 1 year or until death; technical and clinical success rates were both 100%. No cholecystitis occurred despite the presence of reported risk factors for cholecystitis: cholelithiasis or sludge (65%), contrast filling of the gallbladder (35%), and tumor involvement of the cystic duct (15%). Recurrent biliary obstruction occurred in six patients (30%): two stent migrations, three occlusions, and one biliary kinking. All recurrent biliary obstruction cases were managed endoscopically. Median time to recurrent biliary obstruction was not reached. One-year stent patency rate was 62%. Adverse events other than recurrent biliary obstruction were mild. No cholecystitis occurred after MHSEMS placement in this small prospective cohort, suggesting a favorable safety profile; however, larger comparative studies are needed to clarify its effect. UMIN000051182; registered June 1, 2023.
- Open Access
- 30 March 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 59 (2) , 273-279
Feasibility of primary precut sphincterotomy in endoscopic retrograde cholangiopancreatography for patients with large oral protrusions of the duodenal papilla; prospective observation study in Japan
Background/Aims: Large oral protrusions may increase the difficulty of biliary cannulation in endoscopic retrograde cholangiopancreatography (ERCP) and often require precut sphincterotomy. Precut sphincterotomy is a risk factor for post-ERCP pancreatitis (PEP). However, this may be reduced by a primary precut sphincterotomy. This study aimed to evaluate the results of biliary cannulation after primary precut sphincterotomy in patients with large oral protrusions identified during ERCP.Methods: In this prospective observation study, we included 38 patients with naïve papillae who underwent ERCPs between January 2021 and December 2022 that revealed large oral protrusions and who underwent primary precut sphincterotomies as the biliary cannulation method. Primary precut sphincterotomy was performed by an experienced endoscopist in all cases.Results: The biliary cannulation success rate for primary precut sphincterotomies was 100% (38/38 patients). There were seven cases (18.4%) of ERCP-related adverse events, specifically bleeding. Of these, six (15.8%) were mild and one (2.6%) was moderate. No cases of PEP were observed.Conclusions: Primary precut sphincterotomy for large oral protrusions performed by an experienced endoscopist had a high biliary cannulation success rate without the occurrence of PEP. This procedure can be used for biliary cannulation in patients with large oral protrusions (University Hospital Medical Information Network-Clinical Trials Registry number: UMIN000042805).
- 30 March 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 59 (2) , 273-279
Open AccessFeasibility of primary precut sphincterotomy in endoscopic retrograde cholangiopancreatography for patients with large oral protrusions of the duodenal papilla; prospective observation study in Japan
Background/Aims: Large oral protrusions may increase the difficulty of biliary cannulation in endoscopic retrograde cholangiopancreatography (ERCP) and often require precut sphincterotomy. Precut sphincterotomy is a risk factor for post-ERCP pancreatitis (PEP). However, this may be reduced by a primary precut sphincterotomy. This study aimed to evaluate the results of biliary cannulation after primary precut sphincterotomy in patients with large oral protrusions identified during ERCP.Methods: In this prospective observation study, we included 38 patients with naïve papillae who underwent ERCPs between January 2021 and December 2022 that revealed large oral protrusions and who underwent primary precut sphincterotomies as the biliary cannulation method. Primary precut sphincterotomy was performed by an experienced endoscopist in all cases.Results: The biliary cannulation success rate for primary precut sphincterotomies was 100% (38/38 patients). There were seven cases (18.4%) of ERCP-related adverse events, specifically bleeding. Of these, six (15.8%) were mild and one (2.6%) was moderate. No cases of PEP were observed.Conclusions: Primary precut sphincterotomy for large oral protrusions performed by an experienced endoscopist had a high biliary cannulation success rate without the occurrence of PEP. This procedure can be used for biliary cannulation in patients with large oral protrusions (University Hospital Medical Information Network-Clinical Trials Registry number: UMIN000042805).
- Open Access
- 30 November 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (6) , 807-813
Effectiveness of endoscopic ultrasound-guided tissue acquisition with stereomicroscopic on-site evaluation for preoperative diagnosis of resectable or borderline resectable pancreatic cancer: a prospective study
Background/Aims: To validate endoscopic ultrasound-guided tissue acquisition (EUS-TA) used in conjunction with stereomicroscopic on-site evaluation (SOSE) as a preoperative diagnostic tool for resectable pancreatic cancer (R-PC) and borderline resectable PC (BR-PC).Methods: Seventy-eight consecutive patients who underwent EUS-TA for suspected R-PC or BR-PC were enrolled. The primary endpoint was the sensitivity of EUS-TA together with SOSE based on the stereomicroscopically visible white core (SVWC) cutoff value. One or two sites were punctured by using a 22-gauge biopsy needle for EUS-TA, based on the SOSE findings.Results: We collected 99 specimens from 56 and 22 patients with R-PC and BR-PC, respectively. Based on the SOSE results, we performed 57 procedures with one puncture. The SVWC cutoff values were met in 73.7% and 73.1% of all specimens and in those obtained during the first puncture, respectively. The final diagnoses were malignant and benign tumors in 76 and two patients, respectively. The overall sensitivity, specificity, and accuracy of EUS-TA for the 78 lesions were 90.8%, 100%, and 91.0%, respectively. The sensitivity for malignant diagnosis based on the SVWC cutoff value were 89.5% and 90.4% for the first puncture and all specimens, respectively.Conclusions: The sensitivity of EUS-TA in conjunction with SOSE for malignancy diagnosis in patients with suspected R-PC or BR-PC was 90.4%.
- 30 November 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (6) , 807-813
Open AccessEffectiveness of endoscopic ultrasound-guided tissue acquisition with stereomicroscopic on-site evaluation for preoperative diagnosis of resectable or borderline resectable pancreatic cancer: a prospective study
Background/Aims: To validate endoscopic ultrasound-guided tissue acquisition (EUS-TA) used in conjunction with stereomicroscopic on-site evaluation (SOSE) as a preoperative diagnostic tool for resectable pancreatic cancer (R-PC) and borderline resectable PC (BR-PC).Methods: Seventy-eight consecutive patients who underwent EUS-TA for suspected R-PC or BR-PC were enrolled. The primary endpoint was the sensitivity of EUS-TA together with SOSE based on the stereomicroscopically visible white core (SVWC) cutoff value. One or two sites were punctured by using a 22-gauge biopsy needle for EUS-TA, based on the SOSE findings.Results: We collected 99 specimens from 56 and 22 patients with R-PC and BR-PC, respectively. Based on the SOSE results, we performed 57 procedures with one puncture. The SVWC cutoff values were met in 73.7% and 73.1% of all specimens and in those obtained during the first puncture, respectively. The final diagnoses were malignant and benign tumors in 76 and two patients, respectively. The overall sensitivity, specificity, and accuracy of EUS-TA for the 78 lesions were 90.8%, 100%, and 91.0%, respectively. The sensitivity for malignant diagnosis based on the SVWC cutoff value were 89.5% and 90.4% for the first puncture and all specimens, respectively.Conclusions: The sensitivity of EUS-TA in conjunction with SOSE for malignancy diagnosis in patients with suspected R-PC or BR-PC was 90.4%.
- 20 November 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 40 (2) , 502-509
Incidence of Cholecystitis After Endoscopic Biliary Drainage Using a Low Axial Force Covered Self‐Expandable Metallic Stent in Patients With Malignant Distal Biliary Obstruction: A Multicenter Prospective Study
Background and Aim: No prospective studies have verified the incidence of cholecystitis in patients using the covered self‐expandable metallic stent. In this study, we aimed to investigate the incidence of cholecystitis and its risk factors after low axial force covered self‐expandable metallic stent placement for malignant distal biliary obstruction.Methods: This multicenter prospective study included patients diagnosed with unresectable distal biliary obstruction between November 2019 and October 2022 who underwent low axial force covered self‐expandable metallic stent placement.Results: The technical success in the 93 analyzed patients was 100% and clinical success was 98.9%. The 70‐mm covered self‐expandable metallic stent was the most used in 53 patients (57.0%), followed by the 80‐mm type in 27 patients (29.0%), 60‐mm type in 12 patients (12.9%), and 50‐mm type in 1 patient (1.1%). Cholecystitis after covered self‐expandable metallic stent placement occurred in six patients (6.5%). The median time to onset was 46 days (range, 16–315 days), with 1 case in the early stage and five cases in the late stage. There was one mild case, one moderate case, and four severe cases. The presence of tumor involvement at the orifice of the cystic duct was identified as an independent risk factor (odds ratio, 17.0; 95% confidence interval, 1.5–195.1; p = 0.023).Conclusions: The presence of tumor involvement at the orifice of the cystic duct was an independent risk factor for the development of cholecystitis after low axial covered self‐expandable metallic stent placement.Trial registration: University Hospital Medical Information Network (UMIN) (http://www.umin.ac.jp, registration number: UMIN 000038209)
- 20 November 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 40 (2) , 502-509
Incidence of Cholecystitis After Endoscopic Biliary Drainage Using a Low Axial Force Covered Self‐Expandable Metallic Stent in Patients With Malignant Distal Biliary Obstruction: A Multicenter Prospective Study
Background and Aim: No prospective studies have verified the incidence of cholecystitis in patients using the covered self‐expandable metallic stent. In this study, we aimed to investigate the incidence of cholecystitis and its risk factors after low axial force covered self‐expandable metallic stent placement for malignant distal biliary obstruction.Methods: This multicenter prospective study included patients diagnosed with unresectable distal biliary obstruction between November 2019 and October 2022 who underwent low axial force covered self‐expandable metallic stent placement.Results: The technical success in the 93 analyzed patients was 100% and clinical success was 98.9%. The 70‐mm covered self‐expandable metallic stent was the most used in 53 patients (57.0%), followed by the 80‐mm type in 27 patients (29.0%), 60‐mm type in 12 patients (12.9%), and 50‐mm type in 1 patient (1.1%). Cholecystitis after covered self‐expandable metallic stent placement occurred in six patients (6.5%). The median time to onset was 46 days (range, 16–315 days), with 1 case in the early stage and five cases in the late stage. There was one mild case, one moderate case, and four severe cases. The presence of tumor involvement at the orifice of the cystic duct was identified as an independent risk factor (odds ratio, 17.0; 95% confidence interval, 1.5–195.1; p = 0.023).Conclusions: The presence of tumor involvement at the orifice of the cystic duct was an independent risk factor for the development of cholecystitis after low axial covered self‐expandable metallic stent placement.Trial registration: University Hospital Medical Information Network (UMIN) (http://www.umin.ac.jp, registration number: UMIN 000038209)
- 15 May 2024
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 69 (7) , 2567-2572
Endoscopic Ultrasound-Guided Tissue Acquisition Using Fork-Tip Needle for Subepithelial Lesions: A Single-Center Validation Study
Background The cutoff value for stereomicroscopic on-site evaluation (SOSE) in endoscopic ultrasound-guided tissue acquisition (EUS-TA) has high diagnostic sensitivity when a Franseen needle is employed for upper gastrointestinal subepithelial lesions (SELs) (stereomicroscopically visible white core [SVWC] ≥ 4 mm). Aim We aimed to determine whether high diagnostic sensitivity could be obtained when EUS-TA was performed using a Fork-tip needle. Methods Twenty-one patients were prospectively registered. Patients underwent EUS-TA using a Fork-tip needle for upper gastrointestinal SELs at Kitasato University Hospital between January and November 2022. Punctures were made twice using the needle, and SOSE was conducted for each specimen. Blood and physical examination were performed to assess adverse events. Pathological diagnosis was made using hematoxylin and eosin-stained sections and immunohistochemical staining. Statistical comparisons were completed using Fisher’s exact tests. Results The diagnostic rate of EUS-TA was 100% (21/21 cases). The final diagnosis was gastrointestinal stromal tumor in 17 (81.0%) and leiomyoma in 4 (19.0%) patients. SOSE was conducted on all 42 punctures, and the tissue sampling rate was 100% (42/42 punctures). Specimens with SVWC ≥ 4 mm were collected in 97.6% punctures (41/42 punctures) and the diagnostic sensitivity for these specimens was 100% (41/41 punctures), which is significantly higher (p < 0.0238) compared to the absence of cutoff value (diagnostic sensitivity of 0%). No EUS-TA-related adverse events occurred. Conclusions EUS-TA combined with SOSE for upper gastrointestinal SEL using a fork-tip needle had a high diagnostic rate, and the cutoff value of SVWC ≥ 4 mm had high diagnostic sensitivity.
- 15 May 2024
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 69 (7) , 2567-2572
Endoscopic Ultrasound-Guided Tissue Acquisition Using Fork-Tip Needle for Subepithelial Lesions: A Single-Center Validation Study
Background The cutoff value for stereomicroscopic on-site evaluation (SOSE) in endoscopic ultrasound-guided tissue acquisition (EUS-TA) has high diagnostic sensitivity when a Franseen needle is employed for upper gastrointestinal subepithelial lesions (SELs) (stereomicroscopically visible white core [SVWC] ≥ 4 mm). Aim We aimed to determine whether high diagnostic sensitivity could be obtained when EUS-TA was performed using a Fork-tip needle. Methods Twenty-one patients were prospectively registered. Patients underwent EUS-TA using a Fork-tip needle for upper gastrointestinal SELs at Kitasato University Hospital between January and November 2022. Punctures were made twice using the needle, and SOSE was conducted for each specimen. Blood and physical examination were performed to assess adverse events. Pathological diagnosis was made using hematoxylin and eosin-stained sections and immunohistochemical staining. Statistical comparisons were completed using Fisher’s exact tests. Results The diagnostic rate of EUS-TA was 100% (21/21 cases). The final diagnosis was gastrointestinal stromal tumor in 17 (81.0%) and leiomyoma in 4 (19.0%) patients. SOSE was conducted on all 42 punctures, and the tissue sampling rate was 100% (42/42 punctures). Specimens with SVWC ≥ 4 mm were collected in 97.6% punctures (41/42 punctures) and the diagnostic sensitivity for these specimens was 100% (41/41 punctures), which is significantly higher (p < 0.0238) compared to the absence of cutoff value (diagnostic sensitivity of 0%). No EUS-TA-related adverse events occurred. Conclusions EUS-TA combined with SOSE for upper gastrointestinal SEL using a fork-tip needle had a high diagnostic rate, and the cutoff value of SVWC ≥ 4 mm had high diagnostic sensitivity.
- Open Access
- 30 January 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (1) , 89-95
Stereomicroscopic on-site evaluation in endoscopic ultrasound-guided tissue acquisition of upper gastrointestinal subepithelial lesions
Background/Aims: In stereomicroscopic sample isolation processing, the cutoff value (≥4 mm) of stereomicroscopically visible white cores indicates high diagnostic sensitivity. We aimed to evaluate endoscopic ultrasound-guided tissue acquisition (EUS-TA) using a simplified stereomicroscopic on-site evaluation of upper gastrointestinal subepithelial lesions (SELs).Methods: In this multicenter prospective trial, we performed EUS-TA using a 22-gauge Franseen needle in 34 participants with SELs derived from the upper gastrointestinal muscularis propria, requiring pathological diagnosis. The presence of stereomicroscopically visible white core (SVWC) in each specimen was assessed using stereomicroscopic on-site evaluation. The primary outcome was EUS-TA’s diagnostic sensitivity with stereomicroscopic on-site evaluation based on the SVWC cutoff value (≥4 mm) for malignant upper gastrointestinal SELs.Results: The total number of punctures was 68; 61 specimens (89.7%) contained stereomicroscopically visible white cores ≥4 mm in size. The final diagnoses were gastrointestinal stromal tumor, leiomyoma, and schwannoma in 76.5%, 14.7%, and 8.8% of the cases, respectively. The sensitivity of EUS-TA with stereomicroscopic on-site evaluation based on the SVWC cutoff value for malignant SELs was 100%. The per-lesion accuracy of histological diagnosis reached the highest level (100%) at the second puncture.Conclusions: Stereomicroscopic on-site evaluation showed high diagnostic sensitivity and could be a new method for diagnosing upper gastrointestinal SELs using EUS-TA.
- 30 January 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (1) , 89-95
Open AccessStereomicroscopic on-site evaluation in endoscopic ultrasound-guided tissue acquisition of upper gastrointestinal subepithelial lesions
Background/Aims: In stereomicroscopic sample isolation processing, the cutoff value (≥4 mm) of stereomicroscopically visible white cores indicates high diagnostic sensitivity. We aimed to evaluate endoscopic ultrasound-guided tissue acquisition (EUS-TA) using a simplified stereomicroscopic on-site evaluation of upper gastrointestinal subepithelial lesions (SELs).Methods: In this multicenter prospective trial, we performed EUS-TA using a 22-gauge Franseen needle in 34 participants with SELs derived from the upper gastrointestinal muscularis propria, requiring pathological diagnosis. The presence of stereomicroscopically visible white core (SVWC) in each specimen was assessed using stereomicroscopic on-site evaluation. The primary outcome was EUS-TA’s diagnostic sensitivity with stereomicroscopic on-site evaluation based on the SVWC cutoff value (≥4 mm) for malignant upper gastrointestinal SELs.Results: The total number of punctures was 68; 61 specimens (89.7%) contained stereomicroscopically visible white cores ≥4 mm in size. The final diagnoses were gastrointestinal stromal tumor, leiomyoma, and schwannoma in 76.5%, 14.7%, and 8.8% of the cases, respectively. The sensitivity of EUS-TA with stereomicroscopic on-site evaluation based on the SVWC cutoff value for malignant SELs was 100%. The per-lesion accuracy of histological diagnosis reached the highest level (100%) at the second puncture.Conclusions: Stereomicroscopic on-site evaluation showed high diagnostic sensitivity and could be a new method for diagnosing upper gastrointestinal SELs using EUS-TA.
- 16 January 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 39 (4) , 740-745
Efficacy of endoscopic ultrasound‐guided tissue acquisition using stereo‐microscopic on‐site evaluation for possible comprehensive genome profile in patients with advanced pancreatic cancer
Background and Aim: Stereomicroscopic on‐site evaluation (SOSE) is a rapid evaluation method for endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) with a high diagnostic sensitivity when the stereomicroscopically visible white core (SVWC) cut‐off value (≥ 11 mm) is met. We prospectively examined the association between SVWCs and the adequacy of tissue specimens, assuming subsequent comprehensive genome profiling (CGP).Methods: This study included 66 consecutive patients with suspected unresectable pancreatic cancer who underwent EUS‐TA. The primary endpoint was the frequency of combined samples with ≥ 20% tumor cell content that met over twice the SVWC (T‐SVWC) cut‐off value, achieved through multiple punctures. The secondary endpoints were the number of punctures, the percentage of SVWC cut‐off values, adverse events, the positive diagnosis rate, and the tissue section area.Results: The median number of EUS‐TA punctures for suspected unresectable pancreatic cancer was 3 (range, 3–4); SVWC and T‐SVWC cut‐off values were obtained in 171/206 specimens and 65/66 patients, respectively. There were no EUS‐TA‐related adverse events. The positive diagnosis rate of EUS‐TA was 95.5%. Among the 63 patients meeting the T‐SVWC cut‐off value in pathological diagnoses, the median tumor cell content was 40% (range, 5–80%), with 57 patients having tumor cell content ≥ 20%. The median tissue section area was 15 (range, 3–40) mm2.Conclusions: When performing EUS‐TA for unresectable pancreatic cancer with the intention of subsequent CGP, obtaining a high tumor cell content (≥ 20%) by assessing the T‐SVWC cut‐off value via SOSE may serve as a novel indicator for on‐site estimation of CGP suitability for EUS‐TA specimens.
- 16 January 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 39 (4) , 740-745
Efficacy of endoscopic ultrasound‐guided tissue acquisition using stereo‐microscopic on‐site evaluation for possible comprehensive genome profile in patients with advanced pancreatic cancer
Background and Aim: Stereomicroscopic on‐site evaluation (SOSE) is a rapid evaluation method for endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) with a high diagnostic sensitivity when the stereomicroscopically visible white core (SVWC) cut‐off value (≥ 11 mm) is met. We prospectively examined the association between SVWCs and the adequacy of tissue specimens, assuming subsequent comprehensive genome profiling (CGP).Methods: This study included 66 consecutive patients with suspected unresectable pancreatic cancer who underwent EUS‐TA. The primary endpoint was the frequency of combined samples with ≥ 20% tumor cell content that met over twice the SVWC (T‐SVWC) cut‐off value, achieved through multiple punctures. The secondary endpoints were the number of punctures, the percentage of SVWC cut‐off values, adverse events, the positive diagnosis rate, and the tissue section area.Results: The median number of EUS‐TA punctures for suspected unresectable pancreatic cancer was 3 (range, 3–4); SVWC and T‐SVWC cut‐off values were obtained in 171/206 specimens and 65/66 patients, respectively. There were no EUS‐TA‐related adverse events. The positive diagnosis rate of EUS‐TA was 95.5%. Among the 63 patients meeting the T‐SVWC cut‐off value in pathological diagnoses, the median tumor cell content was 40% (range, 5–80%), with 57 patients having tumor cell content ≥ 20%. The median tissue section area was 15 (range, 3–40) mm2.Conclusions: When performing EUS‐TA for unresectable pancreatic cancer with the intention of subsequent CGP, obtaining a high tumor cell content (≥ 20%) by assessing the T‐SVWC cut‐off value via SOSE may serve as a novel indicator for on‐site estimation of CGP suitability for EUS‐TA specimens.
- 23 June 2022
- Published by Springer Nature
- p. 85-89
Pancreaticojejunostomy with Forward-Viewing Echoendoscope
- 23 June 2022
- Published by Springer Nature
- p. 85-89
Pancreaticojejunostomy with Forward-Viewing Echoendoscope
- Open Access
- 30 July 2021
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 54 (4) , 589-595
Cholecystitis after Placement of Covered Self-Expandable Metallic Stents in Patients with Distal Malignant Biliary Obstructions
Background/Aims: Cholecystitis can occur after the placement of covered self-expandable metallic stents for distal malignant biliary obstructions. We aimed to identify risk factors for cholecystitis following covered self-expandable metallic stent placement.Methods: We investigated risk factors related to cholecystitis following covered self-expandable metallic stent placement in 118 patients with distal malignant biliary obstructions between January 1, 2015 and April 30, 2019. Endoscopic assessments and tumor invasion to the arteries feeding the gallbladder were determined by a pancreaticobiliary endoscopist and a radiologist, respectively.Results: The median patient age was 72 years (men, 61.0%). The flow of the contrast agent into the gallbladder and tumor involvement in the orifice of the cystic duct were observed in 35 (29.7%) and 35 (29.7%) patients, respectively. During the observation period (median, 179 days), cholecystitis occurred in 18 (15.3%) patients. Multivariate analysis revealed the flow of the contrast agent into the gallbladder (p=0.023) and tumor involvement in the orifice of the cystic duct (p=0.005) as significant independent risk factors associated with cholecystitis.Conclusions: The flow of the contrast agent into the gallbladder and tumor involvement in the orifice of the cystic duct are potential independent risk factors for cholecystitis following the placement of covered self-expandable metallic stents. A follow-up prospective study is warranted to validate their influence.
- 30 July 2021
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 54 (4) , 589-595
Open AccessCholecystitis after Placement of Covered Self-Expandable Metallic Stents in Patients with Distal Malignant Biliary Obstructions
Background/Aims: Cholecystitis can occur after the placement of covered self-expandable metallic stents for distal malignant biliary obstructions. We aimed to identify risk factors for cholecystitis following covered self-expandable metallic stent placement.Methods: We investigated risk factors related to cholecystitis following covered self-expandable metallic stent placement in 118 patients with distal malignant biliary obstructions between January 1, 2015 and April 30, 2019. Endoscopic assessments and tumor invasion to the arteries feeding the gallbladder were determined by a pancreaticobiliary endoscopist and a radiologist, respectively.Results: The median patient age was 72 years (men, 61.0%). The flow of the contrast agent into the gallbladder and tumor involvement in the orifice of the cystic duct were observed in 35 (29.7%) and 35 (29.7%) patients, respectively. During the observation period (median, 179 days), cholecystitis occurred in 18 (15.3%) patients. Multivariate analysis revealed the flow of the contrast agent into the gallbladder (p=0.023) and tumor involvement in the orifice of the cystic duct (p=0.005) as significant independent risk factors associated with cholecystitis.Conclusions: The flow of the contrast agent into the gallbladder and tumor involvement in the orifice of the cystic duct are potential independent risk factors for cholecystitis following the placement of covered self-expandable metallic stents. A follow-up prospective study is warranted to validate their influence.
- Open Access
New image‐processing technology for endoscopic ultrasound‐guided fine‐needle aspiration biopsy specimen evaluation in patients with pancreatic cancer
Objectives: We evaluated the usefulness of a newly developed system with which the total amount of whitish cores in endoscopic ultrasound‐guided fine‐needle aspiration biopsy (EUS‐FNAB) samples is automatically calculated (automated multiband imaging system [AMUS]).Methods: From 30 prospectively enrolled patients suspected of having pancreatic cancer, four EUS‐FNAB specimens per patient were obtained. Following AMUS calculations, two specimens were prepared after stereomicroscopy‐guided manual division into whitish and reddish sections (isolation group), and the other two were prepared without such division (no‐isolation group). The relation of the AMUS results pertaining to the length of the manually measured whitish cores (stereo‐microscopically visible white core [SVWC]) and the sample suitability for pathologic evaluation were analyzed.Results: Histological diagnostic accuracy was 90%; median SVWC length, 14 mm; and median area of whitish core calculated using the AMUS, 13 mm2. The SVWC length correlated with whitish core amount (ρ = 0.83, p < 0.01) and adequacy score (ρ = 0.50, p < 0.01). The whitish core amount correlated with the adequacy score (ρ = 0.40, p < 0.01). The area under the receiver‐operating characteristic curve calculated for whitish core amount with respect to the histological diagnosis was 0.84 (p < 0.01; cutoff ≥ 8 mm2, sensitivity 92.5%). Subgroup analysis (isolation vs. no‐isolation group) revealed no significant between‐group differences in the median histological adequacy (p = 0.27) or tumor cell content ratio (p = 0.28). The median scores for degree of blood contamination were significantly lower in the isolation group than in the no‐isolation group (p < 0.01).Conclusion: AMUS is a simple on‐site verification procedure for determining the appropriate sampling tissue quantity for high diagnostic accuracy.
Open AccessNew image‐processing technology for endoscopic ultrasound‐guided fine‐needle aspiration biopsy specimen evaluation in patients with pancreatic cancer
Objectives: We evaluated the usefulness of a newly developed system with which the total amount of whitish cores in endoscopic ultrasound‐guided fine‐needle aspiration biopsy (EUS‐FNAB) samples is automatically calculated (automated multiband imaging system [AMUS]).Methods: From 30 prospectively enrolled patients suspected of having pancreatic cancer, four EUS‐FNAB specimens per patient were obtained. Following AMUS calculations, two specimens were prepared after stereomicroscopy‐guided manual division into whitish and reddish sections (isolation group), and the other two were prepared without such division (no‐isolation group). The relation of the AMUS results pertaining to the length of the manually measured whitish cores (stereo‐microscopically visible white core [SVWC]) and the sample suitability for pathologic evaluation were analyzed.Results: Histological diagnostic accuracy was 90%; median SVWC length, 14 mm; and median area of whitish core calculated using the AMUS, 13 mm2. The SVWC length correlated with whitish core amount (ρ = 0.83, p < 0.01) and adequacy score (ρ = 0.50, p < 0.01). The whitish core amount correlated with the adequacy score (ρ = 0.40, p < 0.01). The area under the receiver‐operating characteristic curve calculated for whitish core amount with respect to the histological diagnosis was 0.84 (p < 0.01; cutoff ≥ 8 mm2, sensitivity 92.5%). Subgroup analysis (isolation vs. no‐isolation group) revealed no significant between‐group differences in the median histological adequacy (p = 0.27) or tumor cell content ratio (p = 0.28). The median scores for degree of blood contamination were significantly lower in the isolation group than in the no‐isolation group (p < 0.01).Conclusion: AMUS is a simple on‐site verification procedure for determining the appropriate sampling tissue quantity for high diagnostic accuracy.